Predictive value of the National Institutes of Health Stroke Scale and the Mini-Mental State Examination for neurologic outcome after coronary artery bypass graft surgery

Effect of Esketamine on Postoperative Delirium in Patients Undergoing Cardiac Valve Replacement with Cardiopulmonary Bypass: A Randomized Controlled Trial

BACKGROUND

The aim of this study was to investigate the effects of esketamine on the risk of postoperative delirium (POD) in adults undergoing on-pump cardiac valve surgery.

METHODS

In this randomized, triple-blind, controlled trial, 116 adult patients with an American Society of Anesthesiologists (ASA) grade Ⅱ or Ⅲ and a New York Heart Association (NYHA) grade Ⅱ or Ⅲ who underwent cardiac valve surgery with cardiopulmonary bypass were included. Esketamine (0.25 mg/kg) or normal saline was administered intravenously before anesthesia induction. The primary outcome was POD, defined as a positive delirium assessment according to the 3-minute confusion assessment method (CAM) or the confusion assessment method for the intensive care unit (CAM-ICU) on a twice-daily basis for 7 days after surgery. Delirium duration and the delirium subtype were also recorded. The cognitive status of patients was measured according to the Mini-Mental State Examination at baseline, discharge, 30 days postoperatively and 3 months postoperatively.

RESULTS

A total of 112 patients (mean age, 52 years; 53.6% female) were enrolled; 56 were assigned to receive esketamine, and 56 were assigned to receive placebo. POD occurred in 13 (23.2%) patients in the esketamine group and in 25 (44.6%) patients in the placebo group (relative risk [RR], 0.52, 95% confidence interval [CI], 0.28-0.91; P = .018). Thirteen patients (23.2%) in the esketamine group and 24 (42.9%) patients in the placebo group had multiple episodes of delirium (RR, 0.54, 95% CI, 0.28-0.92), and 13 (23.2%) vs 22 (39.3%) patients exhibited the hyperactive subtype.

CONCLUSIONS

A single dose of esketamine (0.25 mg/kg) injected intravenously before anesthesia induction reduced the incidence of delirium in relatively young patients with ASA grade Ⅱ or Ⅲ who underwent on-pump cardiac surgery.

Neurologic complications after cardiopulmonary bypass - A narrative review

Neurologic complications, associated with cardiac surgery and cardiopulmonary bypass (CPB) in adults, are common and can be devastating in some cases. This comprehensive review will not only consider the broad categories of stroke and neurocognitive dysfunction, but it also summarises other neurological complications associated with CPB, and it provides an update about risks, prevention and treatment. Where appropriate, we consider the impact of off-pump techniques upon our understanding of the contribution of CPB to adverse outcomes.

Association between delirium and cognitive change after cardiac surgery

Background

Previous studies provide inconsistent data on whether postoperative delirium (POD) is a risk factor for postoperative cognitive decline (POCD). We thus investigated the relationship between POD and cognitive change after cardiac surgery and assessed the relationship between preoperative cognitive domain scores and POD.

Methods

Postoperative delirium was assessed with the Confusion Assessment Method (CAM) adapted for the intensive care unit and the conventional CAM accompanied by chart review. Cognitive function was assessed with a neuropsychological test battery before elective cardiac surgery and 1 month and 1 yr afterwards. Cognitive change was calculated using the Reliable Change Index (RCI). Multiple linear regression was used to adjust for confounding.

Results

Of the 184 patients who completed baseline assessment, 23 (12.5%) developed POD. At 1 month, the decline in cognitive performance was worse in patients with POD [median composite RCI -1.00, interquartile range (IQR) -1.67 to 0.28] than in patients without POD (RCI -0.04, IQR -0.70 to 0.63, P =0.02). At 1 yr, both groups showed cognitive improvement on average compared with baseline (POD patients median composite RCI 0.25, IQR -0.42 to 1.31, vs non-POD patients RCI 0.92, IQR 0.18-1.53; P =0.08). Correction for differences in age and level of education did not change the results. Patients with POD performed less well than patients without POD on the preoperative Trailmaking test part A ( P =0.03).

Conclusions

Postoperative delirium is independently associated with cognitive decline 1 month after surgery, but cognitive performance generally recovers in 1 yr. Patients with a predisposition to POD can be identified before surgery by worse performance in an attention task.

Clinical trial registration

NCT00293592.

Cognitive function and oxidative stress after carotid endarterectomy: comparison of propofol to sevoflurane anesthesia

OBJECTIVE

To examine the antioxidant role of propofol in ischemia-reperfusion during carotid endarterectomy (CEA) and its influence on cognitive dysfunction after CEA.

DESIGN

A randomized prospective study.

SETTING

Single-center study in a university hospital.

PARTICIPANTS

Forty-four patients.

INTERVENTIONS

Patients underwent elective CEA under general anesthesia with either sevoflurane (group S, n = 21) or propofol (group P, n = 23).

MEASUREMENTS AND MAIN RESULTS

Cognitive function was assessed with the Mini-Mental State Examination (MMSE) before CEA, 1 hour after CEA, and 24 hours after CEA. Blood samples from the radial artery and the internal jugular vein were drawn before carotid clamping and 5 minutes following unclamping, and peripheral blood was obtained 24 hours postoperatively. Samples were analyzed for lactate, S100B, and P-selectin concentrations and for the antioxidative markers malondialdehyde/low-density lipoprotein ratio and nitrate + nitrite concentrations. Compared with group S, patients in group P exhibited a greater increase in their MMSE values 24 hours postoperatively. Patients who had their MMSE performance reduced at 24 hours also were significantly fewer in group P (13% v 43% in group S, p<0.05). Significantly lower levels of lactate and S100B were observed in arterial and jugular vein samples in group P. In addition, the jugular vein-arterial differences of malondialdehyde-to-low-density lipoprotein ratio and nitrates + nitrites concentrations were lower during propofol anesthesia.

CONCLUSIONS

Propofol seemed to improve cognitive performance after CEA. This improvement was associated with decreased indices of ischemic cerebral damage and seemed to be due to antioxidative effect in the ischemic cerebral circulation.

Impact of preexisting cerebral ischemia detected by magnetic resonance imaging and angiography on late outcome after coronary artery bypass surgery

BACKGROUND

The aim of this study was to assess the impact of preexisting ischemia detected by brain magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) on long-term survival, and cardiac and neurologic events after coronary artery bypass grafting (CABG).

METHODS

Of 923 patients who underwent CABG between 1994 and 2007, 887 patients (96.1%) were followed up. Preoperative brain MRI and MRA were performed in 619 patients. Ischemia was detected by brain MRI and MRA in 158 patients (group A), but not in 461 patients (group B). Preoperative characteristics, follow-up survival, and cardiac and neurological events were investigated.

RESULTS

The average follow-up period was 6.0 ± 4.3 years. Univariate analysis showed that patients in group A (68.5 ± 6.5 years) were older than those in group B (64.5 ± 8.6 years) (p = 0.0001). Preoperative left ventricular ejection fraction was less in group A (0.516 ± 0.175) than in group B (0.556 ± 0.165) (p = 0.02). The prevalence of peripheral vascular disease was higher in group A (14 patients: 8.9%) than in group B (11 patients: 2.4%) (p = 0.001). The rate of on-pump CABG was lower in group A (115 patients; 72.8%) than in group B (383 patients; 83.1%) (p = 0.007). Survival rate was significantly lower (p = 0.062), and freedom from major adverse cardiac event or stroke were significantly lower in group A (p = 0.0002, and p = 0.0001, respectively; log-rank test). However, the Cox proportional hazard model showed that preoperative brain ischemia detected by brain MRI and MRA affected only freedom from neurologic events (p = 0.02; hazard ratio 2.52; 95% confidence interval 1.13 to 5.62), but not survival (p = 0.67) or major adverse cardiac event (p = 0.09).

CONCLUSIONS

Preexisting ischemic findings on brain MRI and MRA in patients who underwent CABG were related only to long-term freedom from stroke, but were not related to survival or major adverse cardiac event.

[Intensive therapy after solid organ transplantation]

Transplantationsmedizin ist eine interdisziplinäre Aufgabe. Oberstes Ziel ist die schnelle Wiederherstellung der individuellen Eigenständigkeit des Patienten. Nach einer Nierentransplantation sind die Überwachung der Organperfusion, ein adäquater Volumenstatus und die Vermeidung einer nephrotoxischen Medikation entscheidend. Die Betreuung von Patienten mit einer weit fortgeschrittenden Leberinsuffizienz ist nach Einführung des „Model-of-end-stage-liver-disease“- (MELD-)Systems häufiger geworden; dies geht mit dem Anstieg des Anteils komplikationsträchtiger Verläufe einher. Die Überwachung der Transplantatfunktion, die Diagnose früher Perfusions- oder Gallengangskomplikationen, eine spezifische Gerinnungssubstitution und die hämodynamische Optimierung im Sinne der Vermeidung einer Leberstauung sind die Eckpunkte der intensivmedizinischen Betreuung. Viele Patienten zur Herztransplantation sind bereits präoperativ aufgrund der stark eingeschränkten Herzfunktion in intensivmedizinischer Behandlung. Eine differenzierte Unterstützung der Transplantatfunktion mithilfe pulmonalarterieller Dilatatoren und Inotropika ist postoperativ regelhaft notwendig. Die Lungentransplantation zielt besonders auf eine Verbesserung der Lebensqualität der Patienten. Postoperativ ist auf die Limitierung des pulmonalarteriellen Drucks, die Vermeidung einer Flüssigkeitsüberladung und die zügige Entwöhnung vom Respirator zu achten.

Intensivtherapie nach Transplantation solider Organe

Der Intensivmedizin kommt eine zentrale Bedeutung in Rahmen der Transplantationsmedizin zu. Aufgrund ihrer marginalen Organfunktion benötigen die Patienten nicht selten bereits im Vorfeld der Transplantation eine intensivmedizinische Versorgung, zu der dann auch die Evaluation und Listung sowie die Koordination des zeitkritischen Transplantationsablaufs gehören können. Die direkte postoperative Betreuung nach komplexen Organtransplantationen bedarf fast ausschließlich der Versorgung im Rahmen von Überwachungsstationen, in denen sowohl direkt transplantationsassoziierte Komplikationen als auch Nebenerkrankungen eine intensivmedizinische Behandlungen notwendig machen. Sie zielt auf die Stabilisierung der Organfunktion, Behandlung begleitender Organdysfunktionen, adäquate Induktion der Immunsuppression und die möglichst frühe Wiedererlangung der Eigenständigkeit des Transplantierten ab.